Skip to main content
Premium Trial:

Request an Annual Quote

UCSF and Genentech Team Up to Study Small Molecules


The University of California, San Francisco, and Roche Group subsidiary Genentech have signed an agreement to collaborate in the discovery and development of drug candidates for the treatment of neurodegenerative diseases.

Genentech will provide the funding for the venture, which will focus on small molecules to target specific proteins or enzymes, modulate biochemical or cellular processes, and have the potential to alter disease states. "Genentech is working on building its expertise in neuroscience research," says company spokeswoman Caroline Pecquet.

A team of Genentech researchers will be working with several scientists at the UCSF Small Molecule Discovery Center, led by Jim Wells, to develop a drug candidate based on Genentech discoveries and prior research conducted at UCSF.

In addition to Genentech's initial financial support, UCSF has the potential for further funding in excess of $13 million from the company if certain development and commercial milestones are met. The university also has the right to certain royalties. Genentech and UCSF both declined to disclose details of the developments or milestones.

The collaboration between the two is an extension of a master research agreement they reached in 2005. Genentech and UCSF have already worked together on research in the fields of asthma and oncology, Pecquet says.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.